DIRUI(SZ:300396)2022-12-06 05:08Group 1: Company Overview - The company specializes in the research, production, and sales of medical testing instruments and related reagents, primarily for urine and blood analysis [1] - Main product categories include urine analysis, formed elements in urine, biochemistry, and blood cell analysis [1] Group 2: Sales Model - The sales model primarily relies on distributors, with direct sales as a supplementary approach [2] - The urine analysis, formed elements analysis, and blood cell analysis products utilize a closed-loop sales model, while biochemical analysis products employ both closed-loop and open sales strategies [2] - The company aims to increase the revenue share of supporting reagent products through tailored discount policies [2] Group 3: Market Reach - Products are sold across various regions in China and exported to over 100 countries, including Germany, the USA, Turkey, and Russia [2] Group 4: Future Strategy - The company aims to become a global service provider for laboratory solutions, enhancing product performance and expanding product variety [2] - Plans for external growth through acquisitions and mergers to integrate innovative products and expand into new business areas [2] Group 5: Product Development - The company is focused on accelerating the development of new products, including automated chemiluminescence immunoassay and gynecological secretion analysis [3] - Ongoing development of various supporting reagents and test strips to broaden the product line [3] Group 6: Corporate Changes - The company has changed its name to better reflect its business structure and future development, enhancing brand image and value [3] - Consideration of stock incentive plans based on the company's actual situation [3]